2025-05-02 08:59:24
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Emmessar Biotech and Nutrition Ltd Q4 FY2023 PAT higher at Rs. 19.69 lakhs
Posted On : 2023-05-20 18:27:17( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.7323 crores during the period ended March 31, 2023 as compared to Rs. 0.8721 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 0.1969 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -0.0220 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 0.38 for the period ended March 31, 2023 as compared to Rs. -0.04 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹0.7323 crs | ₹0.8721 crs |  -16.03% |
| Net Profit | ₹0.1969 crs | ₹-0.0220 crs |  995.00% |
| EPS | ₹0.38 | ₹-0.04 | 1,050.00% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.0.7323 crores during the period ended March 31, 2023 as compared to Rs.0.8524 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.1969 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.0.0347 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.0.38 for the period ended March 31, 2023 as compared to Rs.0.05 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹0.7323 crs | ₹0.8524 crs | -14.09% |
| Net Profit | ₹0.1969 crs | ₹0.0347 crs | 467.44% |
| EPS | ₹0.38 | ₹0.05 | 660.00% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.2.7699 crores during the Financial Year ended March 31, 2023 as compared to Rs.2.2837 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.5038 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.0.4754 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.0.99 for the Financial Year ended March 31, 2023 as compared to Rs.0.94 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹2.7699 crs | ₹2.2837 crs | 21.29% |
| Net Profit | ₹0.5038 crs | ₹0.4754 crs | 5.97% |
| EPS | ₹0.99 | ₹0.94 | 5.32% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 22.72 as compared to the previous close of Rs. 22.94. The total number of shares traded during the day was 1915 in over 28 trades.
The stock hit an intraday high of Rs. 24.01 and intraday low of 22.10. The net turnover during the day was Rs. 44997.00.
